← Evidence map

ReviewPharmaceuticals (Basel, Switzerland)2025

Regulatory Perspectives for AI/ML Implementation in Pharmaceutical GMP Environments.

Sarfaraz K NiaziPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40573297